Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: HEMATOLOGIC NEOPLASMS - COMPLICATIONS , . Treffer: 29

2019

Hoenigl, M; Orasch, T; Faserl, K; Prattes, J; Loeffler, J; Springer, J; Gsaller, F; Reischies, F; Duettmann, W; Raggam, RB; Lindner, H; Haas, H Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.
J Infect. 2019; 78(2):150-157 Doi: 10.1016/j.jinf.2018.09.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koehler, P; Mellinghoff, SC; Lagrou, K; Alanio, A; Arenz, D; Hoenigl, M; Koehler, FC; Lass-Flörl, C; Meis, JF; Richardson, M; Cornely, OA Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.
J Antimicrob Chemother. 2019; 74(6):1704-1712 Doi: 10.1093/jac/dkz051
Web of Science PubMed FullText FullText_MUG

 

2018

Heldt, S; Prattes, J; Eigl, S; Spiess, B; Flick, H; Rabensteiner, J; Johnson, G; Prüller, F; Wölfler, A; Niedrist, T; Boch, T; Neumeister, P; Strohmaier, H; Krause, R; Buchheidt, D; Hoenigl, M Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
J Infect. 2018; 77(3):235-241 Doi: 10.1016/j.jinf.2018.05.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Buchheidt, D; Reinwald, M; Hoenigl, M; Hofmann, WK; Spiess, B; Boch, T The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses.
Curr Opin Infect Dis. 2017; 30(6):539-544 Doi: 10.1097/QCO.0000000000000408
Web of Science PubMed FullText FullText_MUG

 

2016

Duettmann, W; Koidl, C; Krause, R; Lackner, G; Woelfler, A; Hoenigl, M Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection.
Mycoses. 2016; 59(6):374-378 Doi: 10.1111/myc.12482
Web of Science PubMed FullText FullText_MUG

 

Reischies, FM; Raggam, RB; Prattes, J; Krause, R; Eigl, S; List, A; Quehenberger, F; Strenger, V; Wölfler, A; Hoenigl, M Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies.
J Clin Microbiol. 2016; 54(3):771-774 Doi: 10.1128/JCM.02969-15 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Prattes, J; Lackner, M; Eigl, S; Reischies, F; Raggam, RB; Koidl, C; Flick, H; Wurm, R; Palfner, M; Wölfler, A; Neumeister, P; Thornton, CR; Krause, R; Lass-Flörl, C; Hoenigl, M Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
Mycoses. 2015; 58(8):461-469 Doi: 10.1111/myc.12343
Web of Science PubMed FullText FullText_MUG

 

Rabensteiner, J; Theiler, G; Duettmann, W; Zollner-Schwetz, I; Hoenigl, M; Valentin, T; Leitner, E; Luxner, J; Grisold, A; Valentin, A; Neumeister, P; Krause, R Detection of central venous catheter-related bloodstream infections in haematooncological patients.
Eur J Clin Invest. 2015; 45(8):824-832 Doi: 10.1111/eci.12477
Web of Science PubMed FullText FullText_MUG

 

Raggam, RB; Fischbach, LM; Prattes, J; Duettmann, W; Eigl, S; Reischies, F; Wölfler, A; Rabensteiner, J; Prueller, F; Krause, R; Hoenigl, M Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.
Mycoses. 2015; 58(7):394-398 Doi: 10.1111/myc.12328
Web of Science PubMed FullText FullText_MUG

 

2014

Duettmann, W; Koidl, C; Troppan, K; Seeber, K; Buzina, W; Wölfler, A; Wagner, J; Krause, R; Hoenigl, M Serum and urine galactomannan testing for screening in patients with hematological malignancies.
Med Mycol. 2014; 52(6):647-652 Doi: 10.1093/mmy/myu019 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoenigl, M; Duettmann, W; Raggam, RB; Huber-Krassnitzer, B; Theiler, G; Seeber, K; Prueller, F; Zollner-Schwetz, I; Prattes, J; Wagner, J; Wölfler, A; Krause, R Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies.
Int J Antimicrob Agents. 2014; 44(2):140-144 Doi: 10.1016/j.ijantimicag.2014.03.013
Web of Science PubMed FullText FullText_MUG

 

Strenger, V; Meinitzer, A; Donnerer, J; Hofer, N; Dornbusch, HJ; Wanz, U; Seidel, MG; Sperl, D; Lackner, H; Schwinger, W; Sovinz, P; Benesch, M; Urban, C Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.
J Antimicrob Chemother. 2014; 69(9):2522-2526 Doi: 10.1093/jac/dku148 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Herzberg, PY; Lee, SJ; Heussner, P; Mumm, FH; Hilgendorf, I; von Harsdorf, S; Hemmati, P; Rieger, K; Greinix, HT; Freund, M; Holler, E; Wolff, D Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Bone Marrow Transplant. 2013; 48(1):129-134 Doi: 10.1038/bmt.2012.83 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoenigl, M; Seeber, K; Koidl, C; Buzina, W; Wölfler, A; Duettmann, W; Wagner, J; Strenger, V; Krause, R Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
Mycoses. 2013; 56(4):471-476 Doi: 10.1111/myc.12060
Web of Science PubMed FullText FullText_MUG

 

Kuzmina, Z; Krenn, K; Petkov, V; Körmöczi, U; Weigl, R; Rottal, A; Kalhs, P; Mitterbauer, M; Ponhold, L; Dekan, G; Greinix, HT; Pickl, WF CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Blood. 2013; 121(10): 1886-1895. Doi: 10.1182/blood-2012-06-435008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Robier, C; Stettin, M; Neubauer, M Changes in response to antiaggregatory treatment in patients with myeloproliferative neoplasms: a sequential study using multiple electrode aggregometry.
Blood Coagul Fibrinolysis. 2013; 24(8): 869-873. Doi: 10.1097/MBC.0b013e328364713a
Web of Science PubMed FullText FullText_MUG

 

2012

Hoenigl, M; Raggam, RB; Salzer, HJ; Valentin, T; Valentin, A; Zollner-Schwetz, I; Strohmeier, AT; Seeber, K; Wölfler, A; Sill, H; Krause, R Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies.
Int J Antimicrob Agents. 2012; 39(6):510-513 Doi: 10.1016/j.ijantimicag.2012.02.002
Web of Science PubMed FullText FullText_MUG

 

Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Woelfler, A; Seeber, K; Linkesch, W; Krause, R Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Med Mycol. 2012; 50(3):266-269 Doi: 10.3109/13693786.2011.603102 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoenigl, M; Strenger, V; Buzina, W; Valentin, T; Koidl, C; Wölfler, A; Seeber, K; Valentin, A; Strohmeier, AT; Zollner-Schwetz, I; Raggam, RB; Urban, C; Lass-Flörl, C; Linkesch, W; Krause, R European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
J Antimicrob Chemother. 2012; 67(8):2029-2033 Doi: 10.1093/jac/dks155 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Hoenigl, M; Zollner-Schwetz, I; Sill, H; Linkesch, W; Lass-Flörl, C; Schnedl, WJ; Krause, R Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
Mycoses. 2011; 54(5):454-459 Doi: 10.1111/j.1439-0507.2010.01881.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Lackner, H; Sovinz, P; Benesch, M; Aberle, SW; Schwinger, W; Schmidt, S; Strenger, V; Pliemitscher, S; Urban, C The spectrum of parvovirus b19 infection in a pediatric hemato-oncologic ward.
Pediatr Infect Dis J. 2011; 30(5):440-442 Doi: 10.1097/INF.0b013e3182014958
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Schnedl, WJ; Lahousen, T; Krause, R; Wallner, SJ; Piswanger-Soelkner, C; Lipp, RW Evaluation of conditions associated with glycated hemoglobin values below the reference range.
Clin Lab. 2007; 53(3-4):179-181
Web of Science PubMed

 

2006

Wang, XN; Collin, M; Sviland, L; Marshall, S; Jackson, G; Schulz, U; Holler, E; Karrer, S; Greinix, H; Elahi, F; Hromadnikova, I; Dickinson, AM Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Biol Blood Marrow Transplant. 2006; 12(2): 152-159. Doi: 10.1016/j.bbmt.2005.09.018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2005

Staber, PB; Holub, R; Linkesch, W; Schmidt, H; Neumeister, P Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.
BONE MARROW TRANSPLANT. 2005; 35(9): 889-893. Doi: 10.1038/sj.bmt.1704927 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Mulabecirovic, A; Gaulhofer, P; Auner, HW; Popper, H; Krause, R; Hesse, C; Sill, H Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis.
ANN HEMATOL. 2004; 83(7): 420-422. Doi: 10.1007/s00277-004-0876-5
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Rabitsch, W; Knöbl, P; Prinz, E; Keil, F; Greinix, H; Kalhs, P; Worel, N; Jansen, M; Hörl, WH; Derfler, K Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Bone Marrow Transplant. 2003; 32(10):1015-1019 Doi: 10.1038/sj.bmt.1704264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2002

Lackner, H; Moser, A; Benesch, M; Deutsch, J; Kessler, HH; Kerbl, R; Schwinger, W; Dornbusch, HJ; Sovinz, P; Urban, C Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
J Clin Virol. 2002; 25 Suppl 3:S73-S79 Doi: 10.1016/s1386-6532(02)00189-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Harousseau, JL; Dekker, AW; Stamatoullas-Bastard, A; Fassas, A; Linkesch, W; Gouveia, J; De Bock, R; Rovira, M; Seifert, WF; Joosen, H; Peeters, M; De Beule, K Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Antimicrob Agents Chemother. 2000; 44(7):1887-1893 Doi: 10.1128%2FAAC.44.7.1887-1893.2000 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Lackner, H; Moser, A; Deutsch, J; Kessler, HH; Benesch, M; Kerbl, R; Schwinger, W; Dornbusch, HJ; Preisegger, KH; Urban, C Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy.
Pediatrics. 2000; 106(4):E53-E53 Doi: 10.1542/peds.106.4.e53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum